Woodside, CA, United States of America

Guy Laidig

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Guy Laidig

Introduction

Guy Laidig is a prominent inventor based in Woodside, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel heterocyclic compounds. With a total of four patents to his name, Laidig's work has the potential to impact various therapeutic applications.

Latest Patents

Laidig's latest patents include "Heterocyclic glutaminase inhibitors," which relates to novel heterocyclic compounds and pharmaceutical preparations. This invention also encompasses methods of treatment using these innovative compounds. Another notable patent is "Heterocyclic inhibitors of glutaminase," which similarly focuses on novel heterocyclic compounds and their pharmaceutical applications, along with treatment methods.

Career Highlights

Guy Laidig is currently associated with Calithera Biosciences, Inc., where he continues to push the boundaries of pharmaceutical innovation. His expertise in heterocyclic compounds has positioned him as a key player in the industry.

Collaborations

Some of Laidig's notable coworkers include Jim W Li and Lijing Chen, who contribute to the collaborative environment at Calithera Biosciences, Inc. Their combined efforts enhance the research and development of groundbreaking pharmaceutical solutions.

Conclusion

In summary, Guy Laidig's innovative work in the field of pharmaceuticals, particularly through his patents on heterocyclic compounds, showcases his dedication to advancing medical treatments. His contributions are poised to make a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…